Regulations and guidance for human factors research and medtech have evolved, but the goals remain unchanged. The right research partner makes navigating FDA rules simple.
Back to team page
Katie Leyden
Director
Katie’s background in human-centered design, cultural analysis, and business positions her as both a creative and strategic thinker. She brings a cross-disciplinary understanding to ethnographic research and business analysis and has focused on various sectors including technology, e-commerce, entrepreneurship, and housing. She is driven by the desire to understand why people think the way they do and to find solutions for the everyday inconveniences. Katie graduated with a BA from the University of Notre Dame in American Studies with minors in Business Economics and Collaborative Innovation.
Bold facts
Learn more about
Something unique about you summed up in one sentence:
Your favorite part of working at Bold Insight
In your spare time (or if you had spare time), you would absolutely do this:
Your favorite city in the world is...and why?
You cannot start the day without doing this:
Your ultimate celebrity dinner party guest list would include:
Long-term personal or professional goal?
Any other facts to share?
Read our team’s latest bold insights
How collaboration builds value in medical device human factors research
Instead of a top-down, one-size-fits-all approach to research, collaboration between manufacturers and human factors research teams can create trusted partnerships and a focus on designing valuable products.
4 make-or-break considerations for health IoT ecosystems
To boost adoption of IoT devices, medical device manufacturers should consider four key questions to gain insights into user contexts and perceptions.
10 tips to better support a11y participants during user research
With a few considerations and thoughtful planning, research that includes the a11y community can effectively collect data while ensuring a respectful participant experience to help design products that meet the needs of all users.